A recent study detected Oropouche virus (OROV) antibodies in over 6% of tested serum samples across Latin America, highlighting widespread but largely unrecognized transmission. The study conducted large-scale serological testing, modeled transmission risk, and performed genomic analysis, revealing high-risk areas and emphasizing the need for enhanced diagnostics and surveillance to mitigate future outbreaks.

Source: The Lancet Infectious Diseases